Technology News and Research

RSS

Toshiba announces expansion of Assurance Program to offer ultrasound systems

To provide increased value to healthcare facilities, Toshiba America Medical Systems, Inc. expands its Assurance Program to offer reconditioned Toshiba ultrasound systems. Assurance ultrasound products include Aplio XG, Aplio MX, Aplio Artida, Viamo, and Xario XG.

25 Sep 2012

Study uses white matter to study brain function

Most people equate "gray matter" with the brain and its higher functions, such as sensation and perception, but this is only one part of the anatomical puzzle inside our heads. Another cerebral component is the white matter, which makes up about half the brain by volume and serves as the communications network.

25 Sep 2012

SCIOinspire unveils new company name

SCIOinspire Corp., which has served the healthcare marketplace since 2008, today unveiled a new name that reflects its current core focus and corporate identity.

25 Sep 2012

FIOCRUZ, DNDi and Brazil collaborate on R&D for neglected diseases

At the opening ceremony of the XVIII International Congress for Tropical Medicines and Malaria (ICTMM) and the XLVIII Congress of the Brazilian Society of Tropical Medicine in Rio de Janeiro, the Ministry of Health of Brazil signed a Cooperation and Technical Assistance Agreement with the Oswaldo Cruz Foundation (FIOCRUZ) and the Drugs for Neglected Diseases initiative (DNDi) Latin America, uniting the three actors into a strategic partnership to collaborate on research and development (R&D) for new therapies and diagnostics for neglected diseases.

25 Sep 2012

Viewpoints: How media missed Ryan AARP story; Romney and women voters; The price of medical mistakes

The headlines this weekend were all about the boos Paul Ryan elicited on Friday when he addressed the AARP, the self-styled seniors' lobby. The herd of independent media minds missed the real story, which is that the Republican Vice Presidential nominee went into the heart of the entitlement culture, told some hard truths, and even won applause for doing so.

25 Sep 2012

New nanotechnology detects micrometastases in mouse models of breast cancer

Malignant cells that leave a primary tumor, travel the bloodstream and grow out of control in new locations cause the vast majority of cancer deaths. New nanotechnology developed at Case Western Reserve University detects these metastases in mouse models of breast cancer far earlier than current methods, a step toward earlier, life-saving diagnosis and treatment.

25 Sep 2012

PAM50 potentially simplifies underlying breast tumor biology

On September 23, researchers published online in the journal Nature a study of the molecular biology of breast cancer, using the intrinsic subtypes as defined by the PAM50 gene signature as an organizing framework for analyzing genomic and proteomic aberrations. This landmark study both underscores the emergence of the intrinsic subtypes as a powerful taxonomy of breast cancer in research, and PAM50's role as the gold standard for categorizing breast cancer by subtype.

From NanoString Technologies 25 Sep 2012

pSivida reports revenues of $699,000 for fourth quarter 2012

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced financial results for its fourth quarter and fiscal year ended June 30, 2012.

25 Sep 2012

The positive or negative impact of health law is in eye of beholder

Some businesses are taking advantage of the health law's requirements as states prepare to implement it.

24 Sep 2012

Advanced optics system noninvasively maps out network of tiny blood vessels beneath the skin

The trained eye of a dermatologist can identify many types of skin lesions, but human sight only goes so far. Now an international team of researchers has developed an advanced optics system to noninvasively map out the network of tiny blood vessels beneath the outer layer of patients' skin, potentially revealing telltale signs of disease.

24 Sep 2012

RXi completes dosing in RXI-109 Phase 1 study for dermal scarring

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that dosing with their first drug in its first Phase 1 study, was completed last week.

24 Sep 2012

Sanofi chooses OnPoint clinical trial management system from BioClinica

BioClinica, Inc., a global provider of clinical trial management services, announced today that Sanofi, one of the world's largest pharmaceutical companies, has selected BioClinica's OnPoint as the company's standard CTMS (Clinical Trial Management System).

From Clario 24 Sep 2012

Molecular similarity between one sub-type of breast cancer and ovarian cancer

A team of scientists with The Cancer Genome Atlas program reports their genetic characterization of 800 breast tumors, including finding some of the genetic causes of the most common forms of breast cancer, providing clues for new therapeutic targets, and identifying a molecular similarity between one sub-type of breast cancer and ovarian cancer.

24 Sep 2012

Consumer Genetics Conference to take place in Boston from Oct. 3-5

The 4th Annual Consumer Genetics Conference, taking place October 3-5 at the Seaport Hotel in Boston, will include a keynote presentation by George Church that will provide a forthright and candid assessment of new sequencing technologies, including the emergence of nanopore DNA sequencing, current trends in personal genomics, and projections on the future path of medical genomics.

24 Sep 2012

UT Arlington to improve connections between nurses and social workers

The University of Texas at Arlington's College of Nursing and School of Social Work will use nearly $900,000 during the next three years to fund research to improve connections between nurses and social workers before they meet in the health care workplace.

24 Sep 2012

Tribogenics closes $6.2M Series A financing round

Tribogenics, a producer of innovative X-ray sources, announced today that it has closed a $6.2 million Series A financing round led by Founders Fund. The company previously received $2.5M in funding from Flywheel Ventures and other angel investors.

24 Sep 2012

Boston Scientific receives regulatory approval to market RELIANCE 4-FRONT in Europe and Asia

Boston Scientific Corporation has received regulatory approval to market the RELIANCE 4-FRONT lead, its next generation implantable defibrillation lead now available in Europe and Asia. Defibrillation leads are insulated wires that connect an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator to the heart for treatment of heart failure and sudden cardiac arrest.

24 Sep 2012

Latest research on stem cells discussed at Einstein symposium

The promise of stem cells seems limitless. If they can be coaxed into rebuilding organs, repairing damaged spinal cords and restoring ravaged immune systems, these malleable cells would revolutionize medical treatment. But stem cell research is still in its infancy, as scientists seek to better understand the role of these cells in normal human development and disease.

24 Sep 2012

UCSD Sulpizio Family Cardiovascular Center receives 2012 Modern Healthcare Design Award

UC San Diego Sulpizio Family Cardiovascular Center has received Modern Healthcare's highest design honor, the 2012 Modern Healthcare Design Award. Out of more than one hundred entries, only one other project received this honor in 2012.

24 Sep 2012

Exposure to near-roadway air pollution can cause or exacerbate asthma in L.A. County children

Research conducted at the University of Southern California (USC) indicates that at least 8 percent of the more than 300,000 cases of childhood asthma in Los Angeles County can be attributed to traffic-related pollution at homes within 75 meters (a little less than 250 feet) of a busy roadway.

24 Sep 2012